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ABSTRACT
In the last decade, novel tick-borne pathogenic phleboviruses in the family Bunyaviridae, all closely related to Uukuniemi virus
(UUKV), have emerged on different continents. To reproduce the tick-mammal switch in vitro, we first established a reverse
genetics system to rescue UUKV with a genome close to that of the authentic virus isolated from the Ixodes ricinus tick reservoir.
The IRE/CTVM19 and IRE/CTVM20 cell lines, both derived from I. ricinus, were susceptible to the virus rescued from plasmid
DNAs and supported production of the virus over many weeks, indicating that infection was persistent. The glycoprotein GC was
mainly highly mannosylated on tick cell-derived viral progeny. The second envelope viral protein, GN, carried mostlyN-glycans
not recognized by the classical glycosidases peptide-N-glycosidase F (PNGase F) and endoglycosidase H (Endo H). Treatment
with-mercaptoethanol did not impact the apparent molecular weight of GN. On viruses originating frommammalian BHK-21
cells, GN glycosylations were exclusively sensitive to PNGase F, and the electrophoretic mobility of the protein was substantially
slower after the reduction of disulfide bonds. Furthermore, the amount of viral nucleoprotein per focus forming unit differed
markedly whether viruses were produced in tick or BHK-21 cells, suggesting a higher infectivity for tick cell-derived viruses. To-
gether, our results indicate that UUKV particles derived from vector tick cells have glycosylation and structural specificities that
may influence the initial infection in mammalian hosts. This study also highlights the importance of working with viruses origi-
nating from arthropod vector cells in investigations of the cell biology of arbovirus transmission and entry into mammalian
hosts.
IMPORTANCE
Tick-borne phleboviruses represent a growing threat to humans globally. Although ticks are important vectors of infectious
emerging diseases, previous studies have mainly involved virus stocks produced in mammalian cells. This limitation tends to
minimize the importance of host alternation in virus transmission to humans and initial infection at the molecular level. With
this study, we have developed an in vitro tick cell-based model that allows production of the tick-borne Uukuniemi virus to high
titers. Using this system, we found that virions derived from tick cells have specific structural properties andN-glycans that may
enhance virus infectivity for mammalian cells. By shedding light onmolecular aspects of tick-derived viral particles, our data
illustrate the importance of considering the host switch in studying early virus-mammalian receptor/cell interactions. The infor-
mation gained here lays the basis for future research on not only tick-borne phleboviruses but also all viruses and other patho-
gens transmitted by ticks.
The Bunyaviridae are the largest family of RNA viruses. Withover 350 members distributed worldwide and classified into
five genera (Tospovirus,Nairovirus,Orthobunyavirus, Phlebovirus,
and Hantavirus), these viruses represent a global threat to public
health, livestock, and agricultural productivity (1). Hantaviruses
apart, bunyaviruses aremainly transmitted by arthropods, includ-
ing sandflies, mosquitoes, and ticks. In the past 5 years, a number
of emerging tick-borne phleboviruses have been reported on dif-
ferent continents. Severe fever with thrombocytopenia syndrome
virus (SFTSV) in Asia and Heartland virus (HRTV) in North
America are recent examples of new tick-borne phleboviruses
causing severe and often fatal disease in humans (2–5). Other
phleboviruses genetically related to SFTSV and HRTV have also
been recently isolated from ticks in different parts of theworld (6).
The increasing number of outbreaks and the apparent wide dis-
tribution in tick reservoirs demonstrate that these viruses must be
taken seriously as emerging agents of disease. Currently, no vac-
cines or treatments are approved for human use.
Tick-borne phleboviruses are enveloped, roughly spherical vi-
ruses, with a diameter of about 100 nm, and have a tripartite,
single-stranded RNA genome that exclusively replicates in the cy-
tosol (7). The large (L) RNA segment codes for the viral RNA-
dependent RNA polymerase L, and the medium (M) segment
codes for the glycoproteins GN and GC, both in a negative-sense
orientation in the viral genomic RNA (vRNA) (7, 8). In addition
to the vector, one of the main distinctions between tick-borne
phleboviruses and the phleboviruses vectored by dipterans or
mosquitoes is the absence of a sequence encoding a nonstructural
protein in theM segment, NSm (7, 8). The small RNA segment (S)
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codes for the nucleoprotein N and the nonstructural protein NSs
in an ambisense manner (7, 8). The proteins N and NSs are trans-
lated from subgenomic mRNAs transcribed from the vRNA and
the antigenomic, replicative-intermediate RNA (cRNA), respec-
tively (7, 8). In the virions, the protein N is associated with the
virus RNA genome and, together with the polymerase L, consti-
tutes the ribonucleoproteins (RNPs) (7). In the virus envelope,
the glycoproteins GN and GC form spike-like projections re-
sponsible for virus attachment to host cells and for acid-acti-
vated penetration by membrane fusion from late endosomal
compartments (7, 9).
During natural transmission to vertebrates, tick-borne phlebo-
viruses are introduced into the skin dermis of hosts following bites
by infected ticks. Although ticks are both harmful parasites and
vectors of several emerging diseases, not only those caused by
phleboviruses, little information on the cell biology of ticks is
available (10–14). As a consequence, the composition and struc-
ture of tick cell-derived phleboviral particles remain largely unde-
fined. Our knowledge of the initial infection of vertebrate hosts,
cellular receptors, and cell entry ismainly based on the use of virus
stocks produced in mammalian cells. SFTSV has been shown to
subvert the nonmuscle myosin heavy chain IIA for early steps of
infection (15). Rhabdoviral particles pseudotyped with the glyco-
proteins of SFTSV (SFTSV-pp) have been found to infect macro-
phages (16). Human dendritic cells (DCs) are productively
infected by many bunyaviruses, including Uukuniemi virus
(UUKV), a phlebovirus originally isolated from the tick Ixodes
ricinus in the 1960s (17–21). To enter and infect DCs, SFTSV-pp
and UUKV have been shown to exploit DC-SIGN, a C-type (cal-
cium-dependent) lectin that binds high-mannose N-glycans on
the viral glycoproteins through its C-terminal carbohydrate rec-
ognition domain (CRD) (16, 17). Interactions with L-SIGN, a
C-type lectin closely related to DC-SIGN but expressed in liver
sinusoidal endothelial cells, have also been recently documented
for SFTSV-pp and UUKV (16, 22). After binding, SFTSV-pp and
UUKV depend on endosomal acidification for penetration and
infection (16, 23). UUKV is a late-penetrating virus, belonging to
a large group of viruses that depend on late endosomalmaturation
for productive entry (9, 23).
We focus here on UUKV, a virus that shares high sequence
homology with SFTSV and HRTV (8, 24, 25). However, UUKV is
not associated with any disease in humans and is a validated bio-
safety level 2 (BSL2) surrogate for arthropod-borne bunyaviruses
of higher biosafety classification (26).Major advances into various
aspects of the phlebovirus life cycle, including virion structure,
receptors, cell entry, and assembly, have been achieved through
the use of UUKV (9, 23, 27–32). To determine whether tick cells
support phlebovirus productive infection in vitro andwhether tick
cell-derived phleboviral particles infect human or other mamma-
lian cells, we rescued UUKV from cDNAs with a genome close to
that of the authentic virus isolated from ticks. Using this system,
we examined infection and virus production in tick cells, assessed
the progeny virus for interactions with DC-SIGN expressed in
mammalian cells, analyzed the glycans and the electrophoretic
mobility of the virus glycoproteins GN and GC, and tested the
infectivity of viral progeny in mammalian cells.
MATERIALS AND METHODS
Cells and viruses. All products used for cell culture were obtained from
Life Technologies or Sigma-Aldrich. Baby hamster kidney cells (BHK-21)
were grown in Glasgow’s minimal essential medium (GMEM) supple-
mentedwith 10% tryptose phosphate broth, 5% fetal bovine serum (FBS),
1%GlutaMAX, 100 units · ml1 penicillin, and 100g · ml1 streptomy-
cin (33). Human B (Raji) and epithelial (HeLa) cells that stably express
DC-SIGN were cultured according to ATCC recommendations (17, 34).
Allmammalian cell lines were grown in an atmosphere of 5%CO2 in air at
37°C. The tick cell lines IRE/CTVM19 and IRE/CTVM20were cultured in
L-15-based medium in sealed, flat-sided tubes (Nunc) in ambient air at
28°C as reported elsewhere (35–37). The prototype UUKV strain 23
(UUKV S23) was originally isolated from the tick I. ricinus in the 1960s
(i.e., the virus in tick suspension) (21). TheUUKVstrain used in this study
results from five successive plaque purifications of UUKV S23 in chicken
embryo fibroblasts (CEFs) and subsequent passages in BHK-21 cells (38,
39). Virus multiplicity of infection is given according to the titer deter-
mined in BHK-21 cells.
Antibodies and reagents.Themousemonoclonal antibodies 8B11A3,
6G9E5, and 3D8B3 are directed against the UUKV nucleoprotein N and
the glycoproteins GN and GC, respectively (40). The rabbit polyclonal
antibodies K1224 andK5 are directed against theUUKVglycoproteinsGN
and GC, respectively (41). All of these antibodies were a kind gift from
Anna O¨verby and the Ludwig Institute for Cancer Research (Stockholm,
Sweden). The rabbit polyclonal antibody U2 has been described previ-
ously and recognizes the UUKV proteins N, GN, and GC (17). The neu-
tralizing anti-DC-SIGN mouse monoclonal antibody IgG2a (mAb1621)
was purchased fromR&DSystems.NH4Cl and EDTAwere obtained from
Sigma-Aldrich and dissolved in deionized water.
Plasmids. The expression plasmids pUUK-N and pUUK-L were a
kind gift fromAnna O¨verby and code for, respectively, theUUKVnucleo-
protein N and polymerase L (39). The cDNAs corresponding to the S, M,
and L segments of UUKV were synthesized by reverse transcription-PCR
(RT-PCR) from vRNA extracts of purified virus stock using the reverse
transcriptase Superscript III (Life Technologies). Their amplification as a
single PCR product was carried out using Herculase II fusion DNA poly-
merase (Agilent). The PCR products were then cloned between the mu-
rine polymerase I (Pol I) RNA polymerase promoter and terminator se-
quences in the pRF108 vector (a generous gift from Ramon Flick,
Bioprotection SystemsCorporation) (30). The resulting Pol I-driven plas-
mids (pRF108-S, pRF108-M, and pRF108-L) encoded each of the antige-
nomic UUKV RNA molecules (i.e., S, M, and L segments). The point
mutation G2386A in theM segment was obtained with a QuikChange XL
site-directed mutagenesis kit (Agilent) using the plasmid pRF108-M as a
template. The complete list of primers and restriction enzymes used for
cloning and mutagenesis is shown in Table 1.
Rescue of UUKV from plasmid DNAs. UUKV was rescued by trans-
fecting BHK-21 cells (0.6 106) with the expression plasmids pUUK-L (1
g) and pUUK-N (0.3 g) together with 0.5 g each of pRF108-S,
pRF108-M, and pRF108-L. Transfectionwas performed in the presence of
Lipofectamine 2000 (Life Technologies) using a ratio of 3.8 l to 1 g of
plasmids in 400 l of Opti-MEM (Life Technologies). At 1 h posttrans-
fection, complete GMEM containing 2% FBS was added to the cells. After
5 days, supernatants were collected, clarified, and titrated as described
below. Rescued viruses were passaged aminimumof five times in BHK-21
cells.
Virus titration by focus-forming assay. Following infection of con-
fluent monolayers with 10-fold dilutions of virus in FBS-free medium,
cells were grown in the presence of medium containing 5% serum and
supplemented with 0.8% carboxymethyl-cellulose to prevent virus
spread. Foci were revealed with a diaminobenzidine solution kit (Vector
Laboratories) after two-step immunostaining with the antibody U2 (1:
1,000) and an anti-rabbit horseradish peroxidase-conjugated secondary
antibody (Vector Laboratories) (23).
Deglycosylation. To assess the glycosylation pattern of the UUKV
glycoproteins, virus stocks purified through a 25% sucrose cushion were
denatured and exposed to one of the five following treatments: 1,000 units
of endoglycosidase H (Endo H; Promega), 5 units of peptide-N-glycosi-
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dase F (PNGase F), 0.005 units of -2(3, 6, 8, 9)-neuraminidase, 0.003
units of-1,4-galactosidase, and 0.05 units of-N-acetylglucosaminidase
(all enzymes fromMerckMillipore) according to the manufacturer’s rec-
ommendations. Samples were then analyzed by SDS-PAGE on a 4 to 12%
or 10% Bis-Tris NuPAGE Novex gel (Life Technologies) and immuno-
blotting.
Protein analysis. Viral protein extracts from virus stocks purified
through a 25% sucrose cushion were analyzed by SDS-PAGE (Nu-PAGE
Novex 4 to 12%Bis-Tris gel; Life Technologies) and transferred to a poly-
vinylidene difluoride (PVDF)membrane (iBlot transfer stacks; Life Tech-
nologies) (17, 23). When indicated in the text, purified viruses were pre-
treated with glycosidases or -mercaptoethanol (40%). For Western blot
analysis, the PVDF membranes were first incubated with primary mouse
monoclonal antibody 8B11A3 (1:2,000), 3D8B3 (1:100), or 6G9E5 (1:
100) or with rabbit polyclonal antibody K5 (1:250 to 1,000), 1224 (1:500
to 1,000) or U2 (1:2,000), all diluted in Tris-buffered saline (TBS) con-
taining 0.1% Tween and 5% milk, and then with an anti-mouse or anti-
rabbit horseradish peroxidase-conjugated secondary antibody (1:10,000;
Santa Cruz), respectively. Bound antibodies were detected by exposure to
enhanced chemiluminescence reagents (ECL; GE Healthcare or Life
Technologies). For quantitative detection of viral proteins, membranes
were first incubated with the rabbit polyclonal antibody U2 (1:1,000) and
then with an anti-rabbit infrared fluorescence (IRDye) secondary anti-
body and analyzed with an Odyssey imaging system and the software
Image Studio (Li-Cor Biosciences).
Infection assays. Mammalian cells were infected with virus at differ-
ent multiplicities of infection (MOIs) in mediumwithout FBS at 37°C for
1 h. Virus supernatant was then replaced by complete culture medium,
and cultures were incubated for up to 64 h before fixation. Tick cells were
exposed to viruses at differentMOIs in culturemedium containing FBS at
28°C for up to 48 h. When used for microscopy, tick cells were seeded on
poly-L-lysine (0.01%)-coated coverslips at 28°C on the day before infec-
tion. For inhibition assays, cells were pretreated with inhibitors at differ-
ent concentrations for 30 min and exposed to UUKV in the continuous
presence of the inhibitors. The infection was monitored by either wide-
field fluorescence microscopy or flow cytometry.
Flow cytometry. The flow cytometry-based infection assay has been
described previously (23). Briefly, after fixation and permeabilization
with 0.1% saponin, infected cells were incubated with the mouse mono-
clonal antibody 8B11A3 (1:400), 6G9E5 (1:400), or 3D8B3 (1:500) at
room temperature for 1 h, washed, and subsequently exposed to Alexa
Fluor 647 (AF647)-conjugated secondary anti-mouse antibodies (1:500;
Life Technologies) at room temperature for 1 h. When the mouse mono-
clonal antibody 1621 (25 g · ml1) was used in infection assays to neu-
tralize DC-SIGN, UUKV-infected cells were immunostained with the
rabbit polyclonal antibody U2 (1:400) and AF647-conjugated secondary
anti-rabbit antibody (1:500; Life Technologies). Flow cytometry-based
analysis involved the use of a FACSCalibur cytometer (BectonDickinson)
and FlowJo software (TreeStar).
Fluorescencemicroscopy. Infected cells were fixed andpermeabilized
with phosphate-buffered saline (PBS) containing 0.1% Triton X-100
(Merck Millipore), incubated with the mouse monoclonal antibody
8B11A3 (1:1,000) at room temperature for 1 h, washed, and then exposed
to AF488-conjugated secondary anti-mouse (1:800; Life Technologies) at
room temperature for 1 h. Nuclei were subsequently stainedwithHoechst
33258 (0.5 g · ml1; Life Technologies). Infection was quantified by
counting cells in three independent fields, and cells were imaged with an
Olympus IX81 microscope.
Statistical analysis.The data shown are representative of at least three
independent experiments. Values are given as the means of triplicates
standard deviations (SD).
Sequencing of the full-length M segment isolated from UUKV-in-
fected ticks. Questing nymphs of the tick I. ricinus were collected in the
region of Ramsvik and Hindens Rev (Sweden; 2013). Pools of 25 nymphs
were homogenized, and the total RNA was extracted with a magnetic
bead-based protocol as described elsewhere (kind gift of Janne Chirico,
National Veterinary Institute, Uppsala, Sweden, and Sara Moutailler,
ANSES,Maisons-Alfort, France) (42). The cDNA corresponding to theM
segment of UUKVwas synthesized by RT-PCRwith the reverse transcrip-
tase Superscript III (Life Technologies) and the specific primer RT-M
(Table 1) before amplification as a single PCR product using the PfuDNA
polymerase (Promega) and the primers UUKV-M-5NC and UUKV-M-
3NC (Table 1). PCR products were analyzed with a capillary sequencer by
ABI (Eurofins Scientific).
Nucleotide sequence accession numbers. The GenBank accession
numbers for the nucleotide sequences of the M segments of the tick iso-
lates RVS and HRS are KX219593 and KX219594, respectively.
RESULTS
Recovery of UUKV S23 from RNA Pol I-driven plasmid DNAs.
The UUKV lab strain that we used in this study as a template for
cloning purposes results from the adaptation of the prototype tick
isolate strain 23 (UUKV S23) to BHK-21 cells after successive
plaque purifications inCEFs (21, 38, 39). Comparedwith the S,M,
and L nucleotide sequences published for the original UUKV S23
that was plaque purified five times in CEFs (GenBank accession
numbers NC_005221.1, NC_005220.1, and NC_005214.1, re-
spectively), we identified only a few mutations in our UUKV lab
strain (Fig. 1A).Most were in theM segment. Over the entire virus
genome, only one mutation was conserved, a nonsilent substitu-
tion (A2386G) in theM transcript (43–45) (Fig. 1A). In all further
TABLE 1 Names and sequences of the primers used for cloning and mutagenesis
Primer Sensea Sequence (5=¡ 3=)b Purposec
RT-S Forw. ACACAAAGACCTCCAACTTAGCTATCG RT, S segment
RT-M Forw. ACACAAAGACGGCTAACATGGTAAGG RT, M segment
RT-L Forw. ACACAAAGACGCCAAGATGCTTTTAGCG RT, L segment
UUKV-S-5NC Forw. AATCGTCTCTAGGTACACAAAGACCTCCAACTTAGCTATCG Cloning the S segment into pRF108
(pRF108-S)UUKV-S-3NC Rev. AATCGTCTCTGGGACACAAAGACCCTCC
UUKV-M-5NC Forw. AATCGTCTCTAGGTACACAAAGACGGCTAACATGGTAAGG Cloning the M segment into pRF108
(pRF108-M)UUKV-M-3NC Rev. AATCGTCTCGGGGACACAAAGACACGGCTACATGG
UUKV-L-5NC Forw. AATCGTCTCTAGGTACACAAAGACGCCAAGATGCTTTTAGCG Cloning the L segment into pRF108
(pRF108-L)UUKV-L-3NC Rev. AATCGTCTCGGGGACACAAAGTCCGCCAAGATGGAAGTAAAGG
Mut-M-S Forw. CAAGGATTCAGTGGATTGTCAATCATCAATCATAGATCCCA Mutagenesis of the M segment
(G2386A)Mut-M-AS Rev. TGGGATCTATGATTGATGATTGACAATCCACTGAATCCTTG
a Forw, forward; Rev, reverse.
b The virus RNA sequence that is targeted is in italics, and the sequences introduced for cloning are in roman type. Underlined nucleotide sequences indicate a BsmBI restriction
site. Bold nucleotides are the point mutations introduced in the M segment sequence of the UUKV lab strain.
c RT, reverse transcription.
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FIG1 RecoveryofUUKVfromPol I-drivenplasmidDNAs. (A)The trisegmented, negative-senseRNAgenomeofUUKV.Theblack arrowhead shows the cleavage site
in the polyprotein precursor of the glycoproteins GN andGC. The black bars indicate the nucleotides found to bemutated in theUUKV laboratory strain relative to the
sequence ofUUKV strain 23. The penetrance of eachmutation is indicated underneath. Four to five cloneswere analyzed for each viral genome segment. (B) Schematic
representation of the Pol I-driven UUKV rescue system. (C) Focus-forming assay used for the titration of UUKV strains. Examples are shown for the UUKV lab strain
(UUKV) and the viruses rescued from plasmid DNAs after five passages in BHK-21 cells (rUUKV and rUUKV S23). After 3 days of incubation at 37°C, foci were
immunostained with the rabbit polyclonal antibody U2 against the viral proteins N, GN, and GC. (D) rUUKV and rUUKV S23 production 5 days after transfection of
plasmids expressing L, M, and S segments under the control of the Pol I promoter together with the UUKV L and N expression plasmids pUUK-L and pUUK-N in
BHK-21cells. (E)Titerof rUUKVandrUUKVS23after rescue (passage0,P0) andup tofivepassages (P1 toP5) inBHK-21cells. FFU, focus-formingunits. (F)Sequence
analysis of the rUUKV S23M segment compared to that of rUUKV carried out from vRNA purified extracts after five passages in BHK-21 cells.
Uukuniemi Virus in Tick Cells
August 2016 Volume 90 Number 15 jvi.asm.org 6787Journal of Virology
 o
n
 August 22, 2016 by INSTITUT PASTEUR-Bibliotheque
http://jvi.asm.org/
D
ow
nloaded from
 
experiments, for convenience, UUKV will refer to our current
mammalian cell culture-adapted lab strain, rUUKV will refer to
the same virus but rescued from cDNAs, UUKV S23 will refer to
the original tick isolate plaque purified five times in CEFs, and
rUUKV S23 will refer to the viral particles produced from plas-
mids encoding genome sequences identical to those published for
UUKV S23 in the late 1980s and early 1990s (43–45).
Using a reverse genetics system that relies on the cellular Pol I
promoter for the synthesis of viral transcripts, the anti-genomic
full-length segments S,M, and L fromUUKVwere cloned into the
vector pRF108, which contains the Pol I promoter and termina-
tor. This system has been successfully employed to synthesize chi-
meric transcripts of the UUKV segment M (30) and to recover
infectious particles of themosquito-borne phlebovirus Rift Valley
fever virus (RVFV) from plasmid DNAs (46, 47). The complete
system is depicted in Fig. 1B. From the plasmids coding for the
genome of UUKV, it was possible to obtain all the segments en-
coding UUKV S23 with only one site-directed mutagenesis
(G2386A in theM segment). This reversion results in the addition
of an arginine instead of a glutamine at position 276 in the se-
quence of the glycoprotein GC.
As there is no evidence for Pol I promoter activity in tick cells,
both rUUKV and rUUKV S23 were first rescued from BHK-21
cells, which are highly permissive to most bunyaviruses. The in-
fectious progenies were detected in the cell culture medium by a
focus-forming assay (Fig. 1C). Both focus formation and growth
properties of the recombinant rUUKV and rUUKV S23 in
BHK-21 cells were similar to those of UUKV (Fig. 1C). Cotrans-
fection of the Pol I-driven full-length S, M, and L plasmids to-
gether with plasmids coding for the viral polymerase L and nu-
cleoprotein N, whose expression depends on the cytomegalovirus
promoter, was essential for the recovery of infectious particles
(data not shown).
The level of infectious rUUKV and rUUKV S23 in the cell
supernatant remained relatively modest 5 days after transfection,
from thousands to hundreds of thousands focus-forming units
(FFU) per milliliter (Fig. 1D). However, the titers significantly
increased over subsequent rounds of amplification in BHK-21
cells and reached a plateau of 107 FFU · ml1 after 2 to 3 passages,
typical for UUKV (17, 23) (Fig. 1E). To assess the identity of the
recombinant virus strains recovered from cDNAs, we used the
point reversion G2386A in the M sequence as a genetic marker.
Total vRNA from rUUKV or rUUKV S23 was extracted after 5
passages in BHK-21 cells, reverse transcribed, and sequenced with
primers spanning the reversion site (Fig. 1F). The sequencing
showed that rUUKV S23 was derived from the transfected plas-
mids and not from contaminating UUKV.
We next analyzed rUUKV particles, infection, replication, and
progeny production in BHK-21 cells in comparison to those of
UUKV.When the viruses were subjected to SDS-PAGE andWest-
ern blotting, all three major structural proteins, namely, N, GN,
and GC, were observed in both rUUKV and UUKV virions (Fig.
2A and B). To monitor infection, we used mouse monoclonal
antibodies against each of the newly synthesized virus proteins,
nucleoprotein N and glycoproteins GN and GC, before flow cy-
tometry analysis (Fig. 2C).UsingNprotein expression as the read-
out, we found that the kinetics of rUUKV infection were quite
similar to those of infection with UUKV (Fig. 2D). The increase in
the proportion of infected cells over time emphasized that viral
replication, and not input virus, was quantified in these assays. A
complete cycle, from binding to release of infectious progeny,
lasted about 6 to 7 h inBHK-21 cells (data not shown) and reached
a plateau after 48 h (Fig. 2E). Similar results were obtained with
rUUKV S23 (data not shown).
Taken together, our results show that infectious viruses with
genomic RNAs identical to those of the original UUKV S23 can be
recovered from cDNAs. In turn, our reverse genetics system can
be confidently used to investigate the life cycle of tick-borne phle-
boviruses in vector tick cells aswell as the subsequent transmission
and initial infection in mammalian hosts. Because the recombi-
nant rUUKV S23 is the model closest to the authentic tick isolate,
we then focused on this strain.
Tick cells are persistently infectedbyUUKV. rUUKVS23 res-
cued in BHK-21 cells was used to infect tick cells and regenerate
virions with all the features of the original tick-derived virus (e.g.,
lipids, glycosylation, etc.). Two cell lines derived from embryos of
I. ricinus, the tick species from which UUKV was first isolated,
were used: IRE/CTVM19 and IRE/CTVM20 (35), obtained from
the Tick Cell Biobank at The Pirbright Institute, United Kingdom.
To determinewhether IRE/CTVM19 and IRE/CTVM20 cells sup-
port infection by tick-borne phleboviruses, they were exposed to
rUUKVS23 for 48 h and immunostainedwithmousemonoclonal
antibodies against the nucleoprotein N of UUKV. Flow cytometry
allowed quantitative detection of infected cells. Independent of
the tick cell line, nearly 50% of cells were infected at a multiplicity
of infection (MOI) of 5, and about 20%were infected at anMOI as
low as 1.25 (Fig. 3A). The sensitivity of tick cells to rUUKV S23
infection was confirmed by fluorescence microscopy after immu-
nostaining of the newly synthesized virus nucleoprotein N (Fig.
3B). These experiments showed that both tick cell lines support
infection of rUUKV S23.
We next assessed infected cells for the production of virus
progeny. Although cells were infected, titration of cell-free super-
natants collected from challenged tick cells indicated that the pro-
duction of infectious rUUKVS23particleswas almost nonexistent
within the first 24 h of infection (data not shown). After this pe-
riod, the amount of infectious progeny produced from both tick
cell lines increased over time to reach a plateau value within 3
weeks (Fig. 3C). Subculturing of infected tick cells 34, 54, and 74
days postinfection, consisting of the removal of half of the cell
suspension and replacement with fresh culture medium, did not
result in a decrease in viral progeny production (indicated by
black arrows in Fig. 3C). At this time, no cytopathic effects were
observed following subculture, and the cells grewnormally. At 100
days postinfection, high levels of infectious virus were still detect-
able despite the subculturing of cells. Similar results were obtained
when rUUKVwas used to infect IRE/CTVM19 and IRE/CTVM20
cells (Fig. 3D). After several months of amplification in tick cells,
the reversion G/A introduced at position 2386 in the M segment
was still present in the genome of rUUKV S23 but not in that of
rUUKV (data not shown). Altogether these data indicate that I.
ricinus cells support persistent infection by recombinant UUKV.
Mammalian cells support infection by rUUKV S23 grown in
tick cells.To examine whether rUUKV S23 derived from tick cells
remains able to infect mammalian cells, BHK-21 cells were ex-
posed to the viral progeny derived from IRE/CTVM19 cells for 18
h. Infected cells were analyzed with conformation-dependent
mouse monoclonal antibodies in a flow cytometry-based assay. A
large proportion of the infected cells were positive for both the
virus nucleoprotein N and glycoproteins GN and GC (Fig. 4A),
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suggesting that infection leads to viral replication. Therefore, our
phlebovirus-tick cell system appears to be an excellent model for
reproducing transmission of tick-borne viruses to mammalian
hosts in vitro.
DC-SIGN mediates infection by tick cell-derived rUUKV
S23.Due to the presence of dermal DCs at the site of initial infec-
tion via tick bite, they are among the first cells to encounter the
incoming viruses (1, 48). We recently established that DC-SIGN,
which is highly expressed on the surface of human dermal DCs,
binds UUKV directly via interactions with high-mannose N-gly-
cans on the virus glycoproteins (17). The capacity of DC-SIGN to
bind tick cell-derived viral particles was therefore evaluated using
Raji and HeLa cells stably expressing the lectin after transduction
with a TRIPU3 lentiviral vector encoding human DC-SIGN
(34). Raji and HeLa cells normally have low or no sensitivity to
phlebovirus infection. As expected, parental Raji cells were not
detectably infected with IRE/CTVM19 cell-derived rUUKV S23 at
an MOI of 5 or less (Fig. 4B). However, when DC-SIGN was ex-
pressed, up to 40% of Raji cells became infected at an MOI of 0.1
(Fig. 4B). Similarly, fluorescence microscopy analysis of HeLa
cells exposed to various MOIs of the virus showed that infection
was greatly increased when the lectin was expressed (Fig. 4C).
To confirm that the infection was mediated by DC-SIGN, we
utilized the neutralizing mouse monoclonal antibody mAb1621
and EDTA, which inhibits the DC-SIGN binding function by ex-
tracting the bound calcium (33). The increase in infectivity due to
DC-SIGN expression was significantly reduced in cells treated
with inhibitors (Fig. 4D). Together, these results clearly indicate
that infection by tick cell-derived rUUKV S23 is mediated by DC-
SIGN and suggest that the viral glycoproteins have, at least in part,
high-mannose carbohydrates recognized by the lectin.
GN andGC present distinct glycosylation profiles on tick and
mammalian cell-derived rUUKV S23 particles. Like other bun-
yaviruses, UUKV has several N-linked oligosaccharides in its en-
velope glycoproteins GN and GC (four sites each). To analyze the
glycosylation pattern of GN and GC on tick cell-derived viruses,
rUUKV S23was treated with peptide-N-glycosidase F (PNGase F)
under denaturing conditions before SDS-PAGE and Western
blotting. When rUUKV S23 was produced in IRE/CTVM19 cells,
at least one N-glycosylation site on GN appeared sensitive to
PNGase F, while all four sites were sensitive when the virus was
derived from BHK-21 cells (Fig. 5A). In contrast, all four of the
N-glycans on the glycoprotein GC were susceptible to the glycosi-
dase regardless of the cells used to produce rUUKV S23 (Fig. 5B).
FIG 2 Characterization of UUKV rescued from plasmids. The UUKV lab strain and rUUKVwere analyzed by SDS-PAGE andWestern blotting under reducing
conditions (A) using the rabbit polyclonal antibody U2 against the three structural viral proteins N, GN, and GC or under nonreducing conditions (B) with the
mouse monoclonal antibodies 8B11A3, 6G9E5, and 3D8B3 that recognize each of the structural proteins N, GN, and GC, respectively. (C) BHK-21 cells were
exposed to the UUKV lab strain or rUUKV at anMOI of 0.1 for 24 h. After fixation and permeabilization, infected cells were immunostained for N, GN, and GC
with the mouse monoclonal antibodies 8B11A3, 6G9E5, and 3D8B3, respectively, and analyzed by flow cytometry. SSC-H, side scatter, height. (D) Infection of
BHK-21 cells by UUKV and rUUKVwasmonitored over 64 h using the flow cytometry-based assay used for the experiment shown in panel C. Infection is given
as the percentage of N protein-positive cells. (E) Supernatants collected from cells infected at an MOI of 0.1 and at indicated times were assessed for the
production of infectious viral progeny by focus-forming assay.
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To further examine the N-glycans on rUUKV S23, the virus
was subjected to endoglycosidase H (EndoH).When rUUKV S23
was amplified inBHK-21 cells, the glycoproteinGN acquired com-
plex glycosylation and was mainly Endo H resistant (Fig. 5C),
while GC carried mainly high-mannose N-glycans, as evidenced
by sensitivity to Endo H digestion (Fig. 5D); i.e., only one site
remained resistant. When the virus was produced in the IRE/
CTVM19 tick line, both glycoproteinsGN andGCwere sensitive to
FIG 3 Infection of tick cells by rUUKV and rUUKV S23 is persistent. (A) Tick cell lines IRE/CTVM19 and IRE/CTVM20 were exposed to BHK-21 cell-derived
rUUKV S23 at the indicatedMOIs for 48 h. Infection was analyzed by flow cytometry after immunostaining against the nucleoprotein N. (B) IRE/CTVM19 and
IRE/CTVM20 cells were exposed to various MOIs of rUUKV S23 derived from BHK-21 cells. The next day, infected cells were immunostained for the
intracellular UUKV nucleoprotein N using the anti-N primary mouse monoclonal antibody 8B11A3 and an AF488-coupled anti-mouse secondary monoclonal
antibody (green). Nuclei were stained with Hoechst (blue), and samples were analyzed by wide-field microscopy. (C and D) IRE/CTVM19 and IRE/CTVM20
cells were exposed to rUUKV S23 and rUUKV, as indicated. Supernatant (200 l) of infected cells was harvested daily during the first 10 days and every 10 days
thereafter. The production of infectious viral particles in the supernatant was determined by focus-forming assays. The cells were subcultured in fresh complete
medium (1:1) after sampling of the parent cells on days 34, 54, and 74 (black arrows).
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Endo H, with a digestion pattern identical to that of PNGase F
(Fig. 5C andD). These results indicate that all theN-glycans onGN
and GC on tick cell-derived virus particles contain, at least, high-
mannose core structures.
Of the two viral envelope glycoproteins, GN shows more strik-
ing differences in glycosylation patterns between tick and BHK-21
cells. To further address these distinctions, rUUKV S23 was ex-
posed to neuraminidase, -1,4-galactosidase, and -N-acetylglu-
cosaminidase, which liberate neuraminic acids, -galactosides,
and terminal -N-acetylglucosamine and N-acetylgalactosamine
residues from oligosaccharides, respectively. GN originating from
tick cells, but not from BHK-21 cells, was sensitive only to -N-
acetylglucosaminidase to a similar extent as PNGase F (Fig. 5E and
F). Overall, our data indicate that UUKV particles derived from
vector tick cells have glycosylation profiles distinct from those in
mammalian cells.
The reductionof disulfidebonds impacts the electrophoresis
mobility of GN derived frommammalian cells but not from tick
cells. Under reducing and nonreducing conditions, the electro-
phoreticmobility of GN on tick cell-derived rUUKV S23 appeared
faster than that of the protein on viral particles originating from
BHK-21 cells (Fig. 5A and 6A, respectively). In contrast, the elec-
trophoretic mobility of GC on tick cell-derived virions appeared
similar to that of the glycoprotein on viruses produced from
BHK-21 cells, under either reducing or nonreducing conditions
(Fig. 5B and 6B, respectively).
We next assessed whether treatment with -mercaptoethanol
results in a change in the apparentmolecularweight ofGNmade in
tick and mammalian cells. When virions produced in BHK-21
cells were analyzed, the electrophoretic mobility of GN appeared
slower under reducing conditions (Fig. 6C). Under our experi-
mental conditions, no shift was observed when the protein origi-
nated from particles derived from tick cells, suggesting that the
number of disulfide bonds differs between GN on tick and mam-
malian cell-derived viruses. Altogether these results suggest that
the viral glycoprotein GN on viruses produced in tick cells has
different maturation and folding properties than those of the pro-
tein on viral particles derived from mammalian cells.
The structural proteins GN, GC, and N in infectious viral
progeny produced in tick andmammalian cells.We then further
examined potential differences in the structure of rUUKV S23
particles derived from tick andmammalian cells. For this purpose,
viruses were purified through a 25% sucrose cushion to retain
only viral particles with an intact envelope. Identical numbers of
infectious particles, based on titration on BHK-21 cells, were an-
alyzed by SDS-PAGE and Western blotting using the polyclonal
FIG 4 The C type lectin DC-SIGN enhances infection of human cells by tick cell-derived rUUKV S23. (A) BHK-21 cells were infected (at an MOI of 0.1) with
rUUKV S23 derived from IRE/CTVM19 cells for 18 h and immunostained for N, GN, and GC proteins prior to flow cytometry analysis. (B) Parental (Raji) and
DC-SIGN-expressing Raji cells (Raji DC-SIGN	) were infected with IRE/CTVM19 cell-derived rUUKV S23 and analyzed by flow cytometry 16 h after
immunostaining against the viral nucleoprotein. (C) Parental (HeLa) and DC-SIGN-expressing HeLa cells (HeLa DC-SIGN	) were exposed to various MOIs
of IRE/CTVM19 cell-derived rUUKV S23. The next day, infected cells were immunostained for the intracellular virus nucleoprotein N using the anti-N primary
mousemonoclonal antibody 8B11A3 and an AF488-coupled anti-mouse secondarymonoclonal antibody (green). Nuclei were stained withHoechst (blue), and
samples were analyzed bywide-fieldmicroscopy. (D) Raji DC-SIGN-expressing cells were exposed to IRE/CTVM19 cell-derived rUUKVS23 (MOI of
1) in the
presence of inhibitors blocking DC-SIGN, namely, EDTA (5 mM) or the neutralizing mouse monoclonal antibody mAb1621 (25 g · ml1). Intracellular viral
antigens were detected by immunostaining with an anti-UUKV rabbit polyclonal antibody, followed by incubation with AF647-conjugated secondary antibod-
ies. Infection was analyzed by flow cytometry 18 h later and normalized to infection of DC-SIGN-expressing Raji cells in the absence of inhibitor (as a percentage
of the control).
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antibody U2 against the whole virus, thereby enabling the detec-
tion of GN, GC, and N. The amounts of nucleoprotein N and
glycoproteins GN and GC appeared markedly different in virions
produced in tick and BHK-21 cells, with substantially less protein
N and more glycoprotein GN and GC in tick cell-derived viruses
(Fig. 7A).
The amounts of GN, GC, and N proteins incorporated into
rUUKV S23 particles were determined by quantitative Western
blotting using the anti-UUKV U2 and an anti-rabbit infrared
fluorescence secondary antibody prior to analysis with anOdyssey
imaging systems. The ratio between the amount of protein N and
the number of FFU was significantly lower in tick cell-derived
viruses (Fig. 7B) while that between the amount of viral glycopro-
teins and number of FFU was greater (Fig. 7C). It was also appar-
ent that the numbers ofGN andGCmolecules per nucleoproteinN
(Fig. 7D) and the number of FFU per N (Fig. 7E) were higher in
virions originating from tick cells. Similar results were obtained
with rUUKV (data not shown). From these results, it ismost likely
that the global structural organizations of viral particles exhibit
differences between viruses produced in tick and mammalian
cells.
Wild-type UUKV originating from Swedish ticks in the
2010s. All RNA viruses are known to have high polymerase error
rates. To determine whether the wild-type UUKV in vector tick
populations has genetically evolved since the 1960s and, thus,
whether our tick-borne virus model is still representative of the
circulating virus, we analyzed 16 pools of 25 nymphs of the tick I.
ricinus recently collected in the region of Ramsvik and Hindens
Rev (Sweden; 2013) for the presence of the UUKV RNA segment
M. The cDNA corresponding to the full-length M segment of
UUKV was first synthesized by RT-PCR from vRNA extracted
with magnetic beads from nymphal homogenates and then am-
plified by a single PCR. Out of the 16 homogenates, 4 were posi-
tive, from which it was possible to obtain the full-length nucleo-
tide M sequence for two samples (GenBank accession numbers
KX219593 and KX219594). Due to limited amounts of material, a
partial sequence was obtained only from one of the two other
samples. Nucleotide sequence analysis showed identity greater
FIG 5 Glycosylation of the rUUKV S23 envelope glycoproteins GN and GC on virions produced from tick and mammalian cells. IRE/CTVM19 and BHK-21
cell-derived rUUKV S23 purified through a 25% sucrose cushion was reduced and denatured before digestion with PNGase F (A, B, E, and F), Endo H (C and
D), or neuraminidase, -1,4-galactosidase, and -N-acetylglucosaminidase (E and F). Proteins were analyzed by SDS-PAGE and Western blotting using the
rabbit polyclonal antibodies K1224 and K5 against linear epitopes in the viral glycoproteins GN (A, C, E, and F) and GC (B and D), respectively.
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than 93% between the UUKV S23 and the virus circulating cur-
rently. At the amino acid level, the sequence identity reached a
minimum of 98.4%, with 7 to 11 amino acid variations located in
GN and 2 to 4 variations in GC (Table 2). Together, our data indi-
cate a modest genetic evolution of UUKV glycoproteins in ticks.
Dependence on low pH of rUUKV S23 infectious entry. We
have recently showed in human, rodent, and monkey cells that
infectious entry of UUKV is pH dependent (23). We examined
whether the envelope proteins GN and GC remain dependent on
endosomal acidification to trigger the infectious entry of tick cell-
derived viruses into mammalian cells. To this end, DC-SIGN-
expressing Raji andHeLa cells were exposed to IRE/CTVM19 cell-
derived rUUKV S23 in the presence of agents that neutralize
vacuolar pH. The lysosomotropic weak base ammonium chloride
(NH4Cl) induced a dose-dependent inhibition of infection in
both cell lines (Fig. 8A andB). Infection of both IRE/CTVM19 and
IRE/CTVM20 cells was also sensitive to NH4Cl (Fig. 8C and D).
Similar results were obtained when chloroquine, another lysoso-
motropic agent, was employed (data not shown). These data show
that rUUKV S23 infection relies on vacuolar acidification regard-
less of the host cell origin of the virus and the targeted cell type.
DISCUSSION
Ticks belong to the Arachnida, a class distinct from that of insects
(Insecta) (49, 50). They are arthropods of huge economic signifi-
cance worldwide, both as harmful ectoparasites and as vectors of
many agents of disease, including protozoan and helminth para-
sites, bacteria, and viruses (10, 50). As obligate parasites, tick-
borne viruses share dependence on biochemical and biophysical
features gained in ticks for production in arthropod vectors and
then transmission to mammalian hosts and other vertebrates.
However, very little is known about themolecular and cell biology
of ticks. In the Bunyaviridae family, a number of novel pathogenic
tick-borne phleboviruses, all closely related to UUKV, have re-
cently emerged in different parts of the world (24, 25). In this
FIG 6 Electrophoretic mobility of the glycoproteins GN and GC on rUUKV
S23 produced in tick and mammalian cells. (A and B) BHK-21 and IRE/
CTVM19 cell-derived rUUKV S23 purified through a 25% sucrose cushion
were analyzed by nonreducing SDS-PAGE and Western blotting, using the
mouse monoclonal antibodies 6G9E5 and 3D8B3 against conformational
epitopes in GN (A) and GC (B), respectively. (C) rUUKV S23 viruses produced
in BHK-21 and IRE/CTVM19 cells were purified through a 25% sucrose cush-
ion and analyzed by nonreducing () or reducing (	) SDS-PAGE andWest-
ern blotting with the rabbit polyclonal anti-GN antibody K1224.
FIG 7 The structural rUUKV S23 proteins GN, GC, and N in infectious parti-
cles derived from tick and mammalian cells. (A) The amounts of viral glyco-
proteins and N protein for 105 and 5  105 focus forming units (FFU) of
purified rUUKV S23, produced in either tick cells or BHK-21 cells, were ana-
lyzed by SDS-PAGE and Western blotting using the rabbit polyclonal anti-
UUKV antibodyU2, which recognized GN, GC, andN. (B to E) The amount of
viral glycoproteins and protein N for identical amounts of purified infectious
rUUKV S23 was determined by quantitativeWestern blotting (Odyssey Imag-
ing Systems) with the anti-UUKVU2 and an anti-rabbit infrared fluorescence
secondary antibody. The ratios of the amounts of N protein (B) or viral glyco-
proteins (C) per FFU and the ratios of the amounts of viral glycoproteins (D)
or number of FFU (E) per relative unit of N protein are shown.
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context, there is renewed interest in using UUKV as a model sys-
tem to examine the initial infection of human hosts by these
emerging pathogenic viruses.
The orthobunyavirus Bunyamwera virus was the first bunya-
virus for which a reverse genetics system was developed to allow
the recovery of infectious viral particles from plasmid DNAs (51).
Since then, similar or derivative methods have been adapted to
some other bunyaviruses, including the tick-borne phlebovirus
SFTSV (1, 52–55). In this study, we have added UUKV to the list
with a reverse genetics system that relies on the use of the cellular
RNA Pol I promoter, enabling modification of the viral genome.
TheUUKVparticles recovered from plasmids were infectious and
had replication characteristics similar to those of the authentic
virus. An alternative approach to rescuing UUKV from cDNAs
that utilizes the T7 promoter was recently described (56). In con-
trast to thatmethod, our Pol I-driven system requires the cotrans-
fection of plasmids coding for the proteins N and L to trigger viral
replication and production. Thismay be explained by the fact that
the RNA transcripts under the control of the T7 promoter are
exclusively processed in the cytosol, while those regulated by the
Pol I promoter follow the classical cellular mRNA maturation
cycle through the nucleus. The main critical advantage of our
system concerns the stability of the rescued virus, which we
showed to be stable after long-term passage.
The reference UUKV strain 23 was isolated from the tick I.
ricinus in the 1960s and then adapted to tissue culture, being pas-
saged and amplified over many years, first in chicken embryo cells
and subsequently in BHK-21 cells (23, 39, 57). However, the nu-
cleotide sequences of the three RNA segments of our UUKV lab
strain did not exhibit major evolution compared to those pub-
lished for the initial virus. As a consequence of this conservation,
remarkably high for an RNA virus, it was possible to obtain all the
original UUKV RNA transcripts with only one site-directed mu-
tagenesis in the sequence coding for the glycoprotein GC. In addi-
tion, this single mutation does not seem to confer any significant
advantages to the virus in terms of infectivity and replication ca-
pacity in either tick or mammalian cells.
When UUKV S23 was compared with viruses currently circu-
lating in tick populations, we found a rather modest number of
point mutations in the nucleotide sequence of the M segment,
which codes for the glycoproteins GN and GC. Furthermore, most
of these mutations were silent at the amino acid level, with se-
quence identities reaching 98% and higher. It is not possible to
conclude whether the few differences result from (i) the genetic
evolution of the virus since the 1960s, (ii) different sites for the
collection of ticks (i.e., Finland for strain 23 and Sweden for the
new isolates), or (iii) adaptation of strain 23 to tissue culture.
However, while cloning the circulating virus in our reverse genet-
ics system for future investigations into the new point mutations
remains paramount, it is apparent that our tick cell-virus model
already allows for addressingmany aspects of both the cell biology
of ticks and the early steps of initial infection inmammalian hosts,
from virus transmission to entry.
Several bunyaviruses are vectored by ticks: a few orthobunya-
viruses, all the nairoviruses, and all of the phleboviruses related to
UUKV (1, 49, 58). While some tick cell lines have been shown to
be sensitive to bunyaviruses, including the nairovirus Crimean-
Congo hemorrhagic fever virus, we have extended these observa-
tions to tick-borne phleboviruses (49). We found that both the
IRE/CTVM19 and IRE/CTVM20 cell lines originating from the
tick I. ricinus are sensitive to UUKV. Both lines supported a com-
plete virus life cycle, from infectious entry to release of new infec-
tious progeny. Although the interaction of additional phlebovi-
ruseswith tick cell linesmust be assessed experimentally, it is likely
that many lines can be infected by tick-borne phleboviruses.
Arthropod-borne viruses infecting humans and other animals
are generally maintained in arthropod vectors and amplified in
nonhuman vertebrates. This is also the case for bunyaviruses (1).
In contrast to vertebrate hosts, there is no clear evidence of pathol-
ogy or lethal outcomes following bunyavirus infection in arthro-
pod hosts. In line with these observations, IRE/CTVM19 and IRE/
CTVM20 cells infected by UUKV grew normally without any sign
of cytopathic effects for many weeks, as reported previously for
other arboviruses propagated in tick cell lines (49). Cells exposed
to UUKV remained infected for months, demonstrating the
asymptomatic persistence of UUKV infection in tick cells. This
contrasts with the inability of mammalian cells to survive infec-
tion after a couple of days. In UUKV, we have found a suitable
surrogate to study important emerging tick-borne pathogens such
as SFTSV and HRTV in both tick vectors and mammalian host
cells, as well as to reproduce host alternation in vitro.
Previous studies havemainly involved virus stocks produced in
mammalian cells. As a consequence, tick-arbovirus interactions
are poorly understood at the cellular level, and the characteristics
of viral particles produced from ticks are largely unknown. Using
our model system to produce UUKV particles with a genome and
biophysical properties very close to those of the virus isolated from
ticks, we applied immunoblotting-based approaches to analyze
TABLE 2 Full-length sequence of the viral glycoproteins GN and GC
obtained from UUKV-infected field Ixodes ricinus nymphal ticks
Region (aa)a Isolate
Identity
(%)b
Positive
sequence
(%)c
Substitution(s) relative
to the UUKV S23
polypeptide precursord
GN (18–496) RVS 98.5 99.6 L8I, L29I, S124T,
T167S, L207V,
A219T, T237A
HRS 97.6 98.7 L29I, T44A, S124T,
T167S, L207V,
A219T, S282T,
T287A, N476K,
N477Q, A479C
Intraregion RVS 100.0 100.0
(497–513) HRS 97.1 97.1 A508T
GC (514–1008) RVS 99.6 100.0 S695T, Q790R
HRS 99.2 99.8 K577R, Q790R,
T841S, L1003F
a Amino acid (aa) position.
b Percent identity relative to the sequence of the precursor peptide.
c Values represent the percent identity of the sequence of interest augmented by the
substitutions shown in boldface, which are assumed to have a weak impact, relative to
the sequence of the precursor protein.
d Total RNAs were extracted from 16 pools of 25 nymphs collected in the region of
Ramsvik and Hindens Rev, Sweden, in 2013. The cDNA corresponding to the M
segment of UUKV was synthesized by RT-PCR and amplified by a single PCR. Out of
the 16 nymphal pools, four were positive for the virus, and from these four samples,
one partial and two full-length nucleotide sequences could be obtained and. The list is
shown of the amino acids found to be mutated in the full-length amino acid sequences
of isolates RVS and HRS (GenBank accession numbers KX219593 and KX219594,
respectively) relative to the sequence of the polypeptide precursor of the two
glycoproteins GN and GC of UUKV S23 (GenBank accession number NC_005220.1).
The point mutations in boldface indicate positive substitutions.
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the envelope glycoproteins GN and GC on tick cell-derived prog-
eny virions. To different extents, both UUKV glycoproteins were
sensitive to PNGase F treatment. This highlights the presence of
classical N-glycan structures on tick cell-derived viral glycopro-
teins, at least in part.
After synthesis in rodent cells, all of the eight N-glycosylation
sites in the UUKV envelope proteins GN and GC were found to
carry oligosaccharides, mainly high-mannose glycans, in previous
studies (17, 23, 29). In the present study, DC-SIGN enhanced
infection of human cells by viruses isolated from tick cells, indi-
cating the existence of high-mannose N-glycans on tick cell-de-
rived glycoproteins. The sensitivity of GN and GC to Endo H
confirmed this presence. It is reasonable to assume that tick cell-
derived viruses have the capacity to target cells expressing such
lectinic virus receptors in the skin dermis following introduction
into humans and other vertebrates by infected ticks and before
subsequent spread throughout the host.
The glycoprotein GN was much less sensitive to PNGase F and
EndoHwhen the virus was isolated from IRE/CTVM19 cells than
when it was isolated from BHK-21 cells. In addition, the -N-
acetylglucosaminidase recognized GN glycosylations only on tick
cell-derived virions. Thoughwe cannot completely exclude differ-
ential glycosylation processes in tick cells, our data rather support
the view that tick cell-derived GN carries atypical glycans not rec-
ognized by the classical glycosidases PNGase F and Endo H. Very
little is known about the nature of oligosaccharides on tick-de-
rived glycoproteins (14, 59). Specific tick glycans may impact the
initial infection of human hosts in the skin dermis by broadening
the spectrum of potential receptors and target cells or by influenc-
ing subsequent entry pathways, especially thosemediated by lectin
receptors. For instance, DC-SIGN is able to trigger selective signal
transduction pathways, which depend on the nature and glycosy-
lation pattern of the captured antigens (60, 61). UUKV can use
distinct lectin receptors for entering cells through different mech-
anisms (22). With regard to this, elucidating the type of glycans
synthesized in tick cells and on derivative viruses remains of par-
amount importance.
Both glycoproteins GN and GC on virions originating from
FIG 8 Low-pH dependence of rUUKV S23 for infection. (A and B) Raji and HeLa cells that stably express DC-SIGN were pretreated with NH4Cl, a weak base
that neutralizes the endosomal pH, and then exposed to IRE/CTVM19 cell-derived rUUKVS23 (MOIof
5) in the continuous presence of the inhibitor. Infected
cells were harvested 16 h later and immunostained for the UUKV nucleoprotein N. Infection was analyzed by flow cytometry (A) or wide-field microscopy
counting at least 200 cells in more than three independent fields (B). Data were normalized to DC-SIGN-expressing cells infected in the absence of inhibitor (as
a percentage of the control). (C and D) IRE/CTVM19 and IRE/CTVM20 cells were infected with BHK-21 cell-derived rUUKV S23 at anMOI of 5 for 36 h in the
continuous presence of NH4Cl. Infectionwas analyzed by flow cytometry and normalized against data obtained in the absence of inhibitor (as a percentage of the
control).
Uukuniemi Virus in Tick Cells
August 2016 Volume 90 Number 15 jvi.asm.org 6795Journal of Virology
 o
n
 August 22, 2016 by INSTITUT PASTEUR-Bibliotheque
http://jvi.asm.org/
D
ow
nloaded from
 
BHK-21 cells showed molecular features distinct from those on
viruses produced in tick cells. GC differed by one N-glycan site,
which remained insensitive to Endo H in BHK-21 cells. The gly-
coprotein GN had a higher degree of dissimilarity, with striking
differences in glycans but also in electrophoretic mobility under
reducing and nonreducing conditions. The apparent molecular
weight ofGNwas lower for viruses produced in IRE/CTVM19 cells
than for those in BHK-21 cells. No deletion in the virus genome
segmentM, which could explain the translation of a smaller-sized
protein, was found after several weeks of virus propagation in tick
cells (data not shown). The smaller size of glycan units or diver-
gent transcription and maturation processes in tick cells may be
responsible for the variation inmolecular weight. In addition, that
only BHK-21 cell-derived GN molecules were sensitive to -mer-
captoethanol indicates a difference in the number of disulfide
bonds between the proteins made in tick and mammalian cells. It
is likely that the folding of GN on virions differs depending on
whether they are produced in tick or mammalian cells.
It is clear from our data that viral particles derived from IRE/
CTVM19 and BHK-21 cells exhibit substantial differences in the
amount of viral structural proteins, with less nucleoprotein N and
moreGN andGC glycoproteins on virions produced in tick cells. It
is tempting to postulate that the level of N protein correlates with
the quantity of RNPs and the number of particles and, therefore,
that the ratio between the number of FFU and amount of N re-
flects the ratio between infectious and noninfectious particles.
This ratio is known to be low for phleboviruses produced inmam-
malian cells (23). Though additional experiments are needed to
confirm this model, production in tick cells arguably confers an
advantage in terms of infectivity to the virus, i.e., with a higher
ratio between infectious and noninfectious particles.
The ratio between the amount of nucleoprotein N and the
amount of glycoproteins GN and GC for tick cell-derived viruses
significantly differs from that for viral particles produced inmam-
malian cells. It is reasonable to believe that virions originating
from tick cells present an overall structure different from that of
the particles derived frommammalian cells. Electron microscopy
pictures and tomography-based approaches have shown pleo-
morphic virions heterogeneous in size for UUKV produced in
BHK-21 cells, with spike-like projections of 5 to 10 nm composed
of the two glycoproteinsGN andGC (27, 32). Structural analyses of
UUKV and other tick-borne viruses obtained from arthropod
vector cells are still lacking.
As with other bunyaviruses, tick-borne phleboviruses rely on
vacuolar acidification for infectious entry into mammalian cells
(1, 9, 16, 23). The fusion of the virus envelope with the cell mem-
branes is triggered following the acidic activation of the viral gly-
coproteins. We found that the presence of NH4Cl resulted in
blockingUUKV infection ofDC-SIGN-expressing human cells by
tick cell-derived viral particles and of both tick cell lines by viruses
produced from BHK-21 cells. In other words, regardless of the
host cells that are targeted or the cells from which the virus origi-
nates, UUKV depends on low pH for penetration and infection.
Structural data support the view that the phlebovirus glycoprotein
GC is the fusion protein (class II) (62). The possible roles of GN in
the entry and fusion processes of UUKV and other tick-borne
phleboviruses and also in host alternation remain to be uncov-
ered.
The lipid composition of the viral envelope, adaptive muta-
tions in the virus genome, and the nature of oligosaccharides in
the virus glycoproteins on tick cell-derived viruses arguably influ-
ence the initial infection in humans and other vertebrates and
subsequent spread throughout the host. Tick cell lines and UUKV
provide an interesting, functional model to investigate not only
tick-borne phleboviruses but alsomany other intracellular patho-
gens transmitted by ticks. The results gained here will open ave-
nues in research on tick vectors, the detailed cell biology of which
remains a challenge for future work.
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